<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002900'>Hypokalemia</z:hpo> is common and can be associated with serious adverse consequences, including <z:hpo ids='HP_0003470'>paralysis</z:hpo>, <z:hpo ids='HP_0002595'>ileus</z:hpo>, <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo>, and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>As a result, the body maintains serum <z:chebi fb="120" ids="26216">potassium</z:chebi> concentration within very narrow limits by tightly regulated feedback and feed-forward systems </plain></SENT>
<SENT sid="2" pm="."><plain>Whereas the consequences of symptomatic <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> and severe <z:chebi fb="120" ids="26216">potassium</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath> are well appreciated, <z:hpo ids='HP_0011010'>chronic</z:hpo> mild <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> can accelerate the progression of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e>, exacerbate <z:hpo ids='HP_0000822'>systemic hypertension</z:hpo>, and increase mortality </plain></SENT>
<SENT sid="3" pm="."><plain>Persistent <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> may reflect total-body <z:chebi fb="120" ids="26216">potassium</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath> or increased renal <z:chebi fb="120" ids="26216">potassium</z:chebi> clearance </plain></SENT>
<SENT sid="4" pm="."><plain>In a patient with simple <z:chebi fb="120" ids="26216">potassium</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath>, <z:chebi fb="120" ids="26216">potassium</z:chebi> replacement therapy should correct serum <z:chebi fb="120" ids="26216">potassium</z:chebi> concentration, but may have little effect when renal <z:chebi fb="120" ids="26216">potassium</z:chebi> clearance is abnormally increased from <z:chebi fb="120" ids="26216">potassium</z:chebi> <z:mp ids='MP_0005150'>wasting</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In such cases, the addition of <z:chebi fb="120" ids="26216">potassium</z:chebi>-sparing <z:chebi fb="40" ids="35498">diuretics</z:chebi> might be helpful </plain></SENT>
<SENT sid="6" pm="."><plain>Serum <z:chebi fb="120" ids="26216">potassium</z:chebi> concentration is an inaccurate marker of total-body <z:chebi fb="120" ids="26216">potassium</z:chebi> deficit </plain></SENT>
<SENT sid="7" pm="."><plain>Mild <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> may be associated with significant total-body <z:chebi fb="120" ids="26216">potassium</z:chebi> deficits and conversely, total-body <z:chebi fb="120" ids="26216">potassium</z:chebi> stores can be <z:mpath ids='MPATH_458'>normal</z:mpath> in patients with <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> due to redistribution </plain></SENT>
<SENT sid="8" pm="."><plain>The speed and extent of <z:chebi fb="120" ids="26216">potassium</z:chebi> replacement should be dictated by the clinical picture and guided by frequent reassessment of serum <z:chebi fb="120" ids="26216">potassium</z:chebi> concentration(.) The goals of therapy should be to correct a <z:chebi fb="120" ids="26216">potassium</z:chebi> deficit, if present, without provoking <z:hpo ids='HP_0002153'>hyperkalemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Oral replacement is preferred except when there is no functioning bowel or in the setting of electrocardiogram changes, neurologic symptoms, <z:mp ids='MP_0004120'>cardiac ischemia</z:mp>, or digitalis therapy </plain></SENT>
</text></document>